(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) fell by a staggering 25.88% in 10 sessions from €0.85 to €0.63 at 14:12 EST on Thursday, after five sequential sessions in a row of losses. BEL 20 is sliding 0.35% to €3,824.82, following the last session’s upward trend. About CELYAD ONCOLOGY Celyad Oncology SA, a…
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) fell by a staggering 23.53% in 10 sessions from €0.85 to €0.65 at 14:07 EST on Wednesday, after five successive sessions in a row of losses. BEL 20 is falling 0.3% to €3,819.64, following the last session’s downward trend. About CELYAD ONCOLOGY Celyad Oncology SA, a…
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) slid by a staggering 22.44% in 10 sessions from €0.85 to €0.66 at 11:09 EST on Tuesday, after four sequential sessions in a row of losses. BEL 20 is falling 0.04% to €3,847.85, after three consecutive sessions in a row of gains. About CELYAD ONCOLOGY Celyad…
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) slid by a staggering 10.32% to €0.68 at 11:08 EST on Thursday, following the last session’s downward trend. BEL 20 is falling 0.03% to €3,800.71, following the last session’s downward trend. This seems, at the moment, a somewhat negative trend trading session today. About CELYAD ONCOLOGY…
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) fell by a staggering 27.08% in 21 sessions from €1.15 to €0.84 at 14:10 EST on Wednesday, following the last session’s downward trend. BEL 20 is jumping 1.23% to €3,712.30, after two sequential sessions in a row of gains. About CELYAD ONCOLOGY Celyad Oncology SA, a…
(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session. The three biggest winners today are CELYAD ONCOLOGY, TARGOVAX, and PROACTIS SA. Financial Asset Price Change Updated (EST) CELYAD ONCOLOGY (CYAD.BR) 0.87 8.61% 2023-03-28 11:08:29 TARGOVAX (TRVX.OL) 0.71 8.18% 2023-03-28 11:35:47…
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) dropped by a staggering 21.35% in 10 sessions from €1.07 to €0.84 at 10:27 EST on Friday, following the last session’s downward trend. BEL 20 is falling 0.63% to €3,634.59, after two sequential sessions in a row of losses. About CELYAD ONCOLOGY Celyad Oncology SA, a…
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) dropped by a staggering 20.07% in 10 sessions from €1.08 to €0.86 at 04:15 EST on Thursday, after two sequential sessions in a row of gains. BEL 20 is falling 0.52% to €3,666.07, following the last session’s downward trend. About CELYAD ONCOLOGY Celyad Oncology SA, a…
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) slid by a staggering 20.07% in 10 sessions from €1.08 to €0.86 at 19:10 EST on Wednesday, after two successive sessions in a row of gains. BEL 20 is dropping 0.52% to €3,666.07, after two successive sessions in a row of gains. About CELYAD ONCOLOGY Celyad…
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) slid by a staggering 29.74% in 21 sessions from €1.22 to €0.86 at 04:14 EST on Wednesday, after five successive sessions in a row of losses. BEL 20 is jumping 1.49% to €3,685.24, after two successive sessions in a row of gains. About CELYAD ONCOLOGY Celyad…
